疗效评价-话题@MedSci

#疗效评价#

21篇内容 | 1559人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2019681, encodeId=0141201968118, content=<a href='/topic/show?id=50aee0412ea' target=_blank style='color:#2F92EE;'>#疗效评价#</a>, objectTitle=iRECIST丨实体肿瘤免疫治疗疗效评价标准, objectType=article, longId=295557, objectId=9b1329555e86, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9b1329555e86, replyNumber=0, likeNumber=0, createdTime=2022-03-31, rootId=0, userName=12498561m32(暂无昵称), userId=d81c2500028, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9b1329555e86, moduleTitle=iRECIST丨实体肿瘤免疫治疗疗效评价标准, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9b1329555e86)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2019683, encodeId=97de2019683e9, content=<a href='/topic/show?id=50aee0412ea' target=_blank style='color:#2F92EE;'>#疗效评价#</a>, objectTitle=JAMA Pediatr：上呼吸道感染期间每日小剂量强的松预防复发性激素敏感型肾病综合征复发的疗效评价, objectType=article, longId=301455, objectId=e01c301455ef, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e01c301455ef, replyNumber=0, likeNumber=99, createdTime=2022-11-12, rootId=0, userName=12498561m32(暂无昵称), userId=d81c2500028, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e01c301455ef, moduleTitle=JAMA Pediatr：上呼吸道感染期间每日小剂量强的松预防复发性激素敏感型肾病综合征复发的疗效评价, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e01c301455ef)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2019682, encodeId=7f9020196828a, content=<a href='/topic/show?id=50aee0412ea' target=_blank style='color:#2F92EE;'>#疗效评价#</a>, objectTitle=中医药治疗心血管疾病疗效评价, objectType=article, longId=300048, objectId=271730004894, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=271730004894, replyNumber=0, likeNumber=105, createdTime=2022-03-20, rootId=0, userName=12498561m32(暂无昵称), userId=d81c2500028, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=271730004894, moduleTitle=中医药治疗心血管疾病疗效评价, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=271730004894)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2019680, encodeId=4cdd2019680c2, content=<a href='/topic/show?id=50aee0412ea' target=_blank style='color:#2F92EE;'>#疗效评价#</a>, objectTitle=免疫治疗长生存优势尽显，治疗疗效评价体系尚待完善, objectType=article, longId=180798, objectId=d375180e983f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d375180e983f, replyNumber=0, likeNumber=81, createdTime=2020-03-30, rootId=0, userName=12498561m32(暂无昵称), userId=d81c2500028, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d375180e983f, moduleTitle=免疫治疗长生存优势尽显，治疗疗效评价体系尚待完善, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d375180e983f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2019679, encodeId=190e20196e9ee, content=<a href='/topic/show?id=50aee0412ea' target=_blank style='color:#2F92EE;'>#疗效评价#</a>, objectTitle=胃肠型感冒诊断与疗效评价专家共识, objectType=article, longId=178040, objectId=32c31e80408c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=32c31e80408c, replyNumber=0, likeNumber=104, createdTime=2019-10-08, rootId=0, userName=12498561m32(暂无昵称), userId=d81c2500028, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=32c31e80408c, moduleTitle=胃肠型感冒诊断与疗效评价专家共识, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=32c31e80408c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2019678, encodeId=0d5120196e893, content=<a href='/topic/show?id=50aee0412ea' target=_blank style='color:#2F92EE;'>#疗效评价#</a>, objectTitle=J CROHNS COLITIS：间充质干细胞治疗克罗恩病肛瘘远期疗效评价, objectType=article, longId=176513, objectId=05b61e65138c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=05b61e65138c, replyNumber=0, likeNumber=69, createdTime=2019-10-22, rootId=0, userName=12498561m32(暂无昵称), userId=d81c2500028, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=05b61e65138c, moduleTitle=J CROHNS COLITIS：间充质干细胞治疗克罗恩病肛瘘远期疗效评价, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=05b61e65138c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2019677, encodeId=e84820196e72c, content=<a href='/topic/show?id=50aee0412ea' target=_blank style='color:#2F92EE;'>#疗效评价#</a>, objectTitle=Pain Res Management：纳布啡与氟比洛芬酯对老年胃肠道开放手术患者腹横肌平面阻滞多模式镇痛疗效评价：随机，对照，双盲试验, objectType=article, longId=159244, objectId=4ecd1592445b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4ecd1592445b, replyNumber=0, likeNumber=72, createdTime=2019-07-21, rootId=0, userName=12498561m32(暂无昵称), userId=d81c2500028, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4ecd1592445b, moduleTitle=Pain Res Management：纳布啡与氟比洛芬酯对老年胃肠道开放手术患者腹横肌平面阻滞多模式镇痛疗效评价：随机，对照，双盲试验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4ecd1592445b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2019675, encodeId=301e20196e502, content=<a href='/topic/show?id=50aee0412ea' target=_blank style='color:#2F92EE;'>#疗效评价#</a>, objectTitle=NEJM：Hu5F9-G4和利妥昔单抗联合阻断非霍奇金淋巴瘤中CD47的疗效评价, objectType=article, longId=152500, objectId=897a152500bf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=897a152500bf, replyNumber=0, likeNumber=83, createdTime=2018-12-31, rootId=0, userName=12498561m32(暂无昵称), userId=d81c2500028, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=897a152500bf, moduleTitle=NEJM：Hu5F9-G4和利妥昔单抗联合阻断非霍奇金淋巴瘤中CD47的疗效评价, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=897a152500bf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2019673, encodeId=670a20196e3db, content=<a href='/topic/show?id=50aee0412ea' target=_blank style='color:#2F92EE;'>#疗效评价#</a>, objectTitle=抗肿瘤免疫治疗irRC疗效评价标准详解, objectType=article, longId=143850, objectId=2a61143850a2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2a61143850a2, replyNumber=0, likeNumber=83, createdTime=2019-04-24, rootId=0, userName=12498561m32(暂无昵称), userId=d81c2500028, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2a61143850a2, moduleTitle=抗肿瘤免疫治疗irRC疗效评价标准详解, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2a61143850a2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2019676, encodeId=e03f20196e672, content=<a href='/topic/show?id=50aee0412ea' target=_blank style='color:#2F92EE;'>#疗效评价#</a>, objectTitle=J Periodontol：上皮下结缔组织移植联合冠状推进皮瓣治疗上颌单发牙龈退缩的远期疗效评价, objectType=article, longId=153606, objectId=064b1536064d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=064b1536064d, replyNumber=0, likeNumber=102, createdTime=2019-09-26, rootId=0, userName=12498561m32(暂无昵称), userId=d81c2500028, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=064b1536064d, moduleTitle=J Periodontol：上皮下结缔组织移植联合冠状推进皮瓣治疗上颌单发牙龈退缩的远期疗效评价, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=064b1536064d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2019672, encodeId=cc3b20196e2f3, content=<a href='/topic/show?id=50aee0412ea' target=_blank style='color:#2F92EE;'>#疗效评价#</a>, objectTitle=JAMA Oncol：前列腺癌临床试验疗效评价指标的探索：OS可以被替代吗？, objectType=article, longId=134560, objectId=4c9b13456006, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4c9b13456006, replyNumber=0, likeNumber=82, createdTime=2018-06-16, rootId=0, userName=12498561m32(暂无昵称), userId=d81c2500028, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4c9b13456006, moduleTitle=JAMA Oncol：前列腺癌临床试验疗效评价指标的探索：OS可以被替代吗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4c9b13456006)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2019674, encodeId=c02520196e4bd, content=<a href='/topic/show?id=50aee0412ea' target=_blank style='color:#2F92EE;'>#疗效评价#</a>, objectTitle=JCO：免疫治疗疗效评价标准imRECIST, objectType=article, longId=143869, objectId=3a2e143869e7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3a2e143869e7, replyNumber=0, likeNumber=81, createdTime=2019-04-24, rootId=0, userName=12498561m32(暂无昵称), userId=d81c2500028, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3a2e143869e7, moduleTitle=JCO：免疫治疗疗效评价标准imRECIST, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3a2e143869e7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2019671, encodeId=89df20196e175, content=<a href='/topic/show?id=50aee0412ea' target=_blank style='color:#2F92EE;'>#疗效评价#</a>, objectTitle=Lancet Oncol：依维莫司、帕瑞肽、依维莫司联合帕瑞肽对肺类癌的疗效评价, objectType=article, longId=118966, objectId=32671189663e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=32671189663e, replyNumber=0, likeNumber=85, createdTime=2017-12-11, rootId=0, userName=12498561m32(暂无昵称), userId=d81c2500028, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=32671189663e, moduleTitle=Lancet Oncol：依维莫司、帕瑞肽、依维莫司联合帕瑞肽对肺类癌的疗效评价, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=32671189663e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2019670, encodeId=9dbf20196e09b, content=<a href='/topic/show?id=50aee0412ea' target=_blank style='color:#2F92EE;'>#疗效评价#</a>, objectTitle=Circulation：细胞疗法对外周动脉疾病运动性能和肢体灌注疗效评价, objectType=article, longId=95892, objectId=6b5a95892c6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6b5a95892c6, replyNumber=0, likeNumber=89, createdTime=2017-12-30, rootId=0, userName=12498561m32(暂无昵称), userId=d81c2500028, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6b5a95892c6, moduleTitle=Circulation：细胞疗法对外周动脉疾病运动性能和肢体灌注疗效评价, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6b5a95892c6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2019668, encodeId=49c3201966808, content=<a href='/topic/show?id=50aee0412ea' target=_blank style='color:#2F92EE;'>#疗效评价#</a>, objectTitle=雾里看花：PD-1/PD-L1抗体疗效评价的困惑, objectType=article, longId=74309, objectId=5773e430947, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5773e430947, replyNumber=0, likeNumber=91, createdTime=2016-09-20, rootId=0, userName=12498561m32(暂无昵称), userId=d81c2500028, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5773e430947, moduleTitle=雾里看花：PD-1/PD-L1抗体疗效评价的困惑, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5773e430947)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2019669, encodeId=6ec12019669b3, content=<a href='/topic/show?id=50aee0412ea' target=_blank style='color:#2F92EE;'>#疗效评价#</a>, objectTitle=2016成人膝关节滑膜炎诊断与临床疗效评价专家共识发布, objectType=article, longId=76827, objectId=b5f6e6827fb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b5f6e6827fb, replyNumber=0, likeNumber=88, createdTime=2016-09-06, rootId=0, userName=12498561m32(暂无昵称), userId=d81c2500028, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b5f6e6827fb, moduleTitle=2016成人膝关节滑膜炎诊断与临床疗效评价专家共识发布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b5f6e6827fb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2019667, encodeId=75e6201966eb9, content=<a href='/topic/show?id=50aee0412ea' target=_blank style='color:#2F92EE;'>#疗效评价#</a>, objectTitle=中国科大发明肿瘤化疗疗效评价成像新方法, objectType=article, longId=66203, objectId=73c96620309, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=73c96620309, replyNumber=0, likeNumber=100, createdTime=2016-11-13, rootId=0, userName=12498561m32(暂无昵称), userId=d81c2500028, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=73c96620309, moduleTitle=中国科大发明肿瘤化疗疗效评价成像新方法, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=73c96620309)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2019664, encodeId=6d3820196649f, content=<a href='/topic/show?id=50aee0412ea' target=_blank style='color:#2F92EE;'>#疗效评价#</a>, objectTitle=Spine：糖尿病患者实施脊柱手术的风险及疗效评价, objectType=article, longId=41190, objectId=900641190f4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=900641190f4, replyNumber=0, likeNumber=99, createdTime=2015-07-07, rootId=0, userName=12498561m32(暂无昵称), userId=d81c2500028, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=900641190f4, moduleTitle=Spine：糖尿病患者实施脊柱手术的风险及疗效评价, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=900641190f4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2019666, encodeId=06b6201966688, content=<a href='/topic/show?id=50aee0412ea' target=_blank style='color:#2F92EE;'>#疗效评价#</a>, objectTitle=Oncol Res Treat：乳腺癌新辅助治疗疗效评价指标大盘点, objectType=article, longId=44532, objectId=94874453217, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=94874453217, replyNumber=0, likeNumber=98, createdTime=2015-01-24, rootId=0, userName=12498561m32(暂无昵称), userId=d81c2500028, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=94874453217, moduleTitle=Oncol Res Treat：乳腺癌新辅助治疗疗效评价指标大盘点, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=94874453217)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2019663, encodeId=3aa92019663a7, content=<a href='/topic/show?id=50aee0412ea' target=_blank style='color:#2F92EE;'>#疗效评价#</a>, objectTitle=RadioGraphics: 肿瘤治疗疗效评价标准的发展, objectType=article, longId=35423, objectId=72723542343, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=72723542343, replyNumber=0, likeNumber=76, createdTime=2014-09-07, rootId=0, userName=12498561m32(暂无昵称), userId=d81c2500028, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=72723542343, moduleTitle=RadioGraphics: 肿瘤治疗疗效评价标准的发展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=72723542343)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

疗效评价

2020-05-29

12498561m32(暂无昵称) (审核中...)

前往app查看评论内容

#疗效评价#

iRECIST丨实体肿瘤免疫治疗疗效评价标准

2022-03-31

12498561m32(暂无昵称) (审核中...)

前往app查看评论内容

#疗效评价#

JAMA Pediatr：上呼吸道感染期间每日小剂量强的松预防复发性激素敏感型肾病综合征复发的疗效评价

2022-11-12

12498561m32(暂无昵称) (审核中...)

前往app查看评论内容

#疗效评价#

中医药治疗心血管疾病疗效评价

2022-03-20

12498561m32(暂无昵称) (审核中...)

前往app查看评论内容

#疗效评价#

免疫治疗长生存优势尽显，治疗疗效评价体系尚待完善

2020-03-30

12498561m32(暂无昵称) (审核中...)

前往app查看评论内容

#疗效评价#

胃肠型感冒诊断与疗效评价专家共识

2019-10-08

12498561m32(暂无昵称) (审核中...)

前往app查看评论内容

#疗效评价#

J CROHNS COLITIS：间充质干细胞治疗克罗恩病肛瘘远期疗效评价

2019-10-22

12498561m32(暂无昵称) (审核中...)

前往app查看评论内容

#疗效评价#

Pain Res Management：纳布啡与氟比洛芬酯对老年胃肠道开放手术患者腹横肌平面阻滞多模式镇痛疗效评价：随机，对照，双盲试验

2019-07-21

12498561m32(暂无昵称) (审核中...)

前往app查看评论内容

#疗效评价#

NEJM：Hu5F9-G4和利妥昔单抗联合阻断非霍奇金淋巴瘤中CD47的疗效评价

2018-12-31

12498561m32(暂无昵称) (审核中...)

前往app查看评论内容

#疗效评价#

抗肿瘤免疫治疗irRC疗效评价标准详解

2019-04-24

12498561m32(暂无昵称) (审核中...)

前往app查看评论内容

#疗效评价#

J Periodontol：上皮下结缔组织移植联合冠状推进皮瓣治疗上颌单发牙龈退缩的远期疗效评价

2019-09-26

12498561m32(暂无昵称) (审核中...)

前往app查看评论内容

#疗效评价#

JAMA Oncol：前列腺癌临床试验疗效评价指标的探索：OS可以被替代吗？

2018-06-16

12498561m32(暂无昵称) (审核中...)

前往app查看评论内容

#疗效评价#

JCO：免疫治疗疗效评价标准imRECIST

2019-04-24

12498561m32(暂无昵称) (审核中...)

前往app查看评论内容

#疗效评价#

Lancet Oncol：依维莫司、帕瑞肽、依维莫司联合帕瑞肽对肺类癌的疗效评价

2017-12-11

12498561m32(暂无昵称) (审核中...)

前往app查看评论内容

#疗效评价#

Circulation：细胞疗法对外周动脉疾病运动性能和肢体灌注疗效评价

2017-12-30

12498561m32(暂无昵称) (审核中...)

前往app查看评论内容

#疗效评价#

雾里看花：PD-1/PD-L1抗体疗效评价的困惑

2016-09-20

12498561m32(暂无昵称) (审核中...)

前往app查看评论内容

#疗效评价#

2016成人膝关节滑膜炎诊断与临床疗效评价专家共识发布

2016-09-06

12498561m32(暂无昵称) (审核中...)

前往app查看评论内容

#疗效评价#

中国科大发明肿瘤化疗疗效评价成像新方法

2016-11-13

12498561m32(暂无昵称) (审核中...)

前往app查看评论内容

#疗效评价#

Spine：糖尿病患者实施脊柱手术的风险及疗效评价

2015-07-07

12498561m32(暂无昵称) (审核中...)

前往app查看评论内容

#疗效评价#

Oncol Res Treat：乳腺癌新辅助治疗疗效评价指标大盘点

2015-01-24

12498561m32(暂无昵称) (审核中...)

前往app查看评论内容

#疗效评价#

RadioGraphics: 肿瘤治疗疗效评价标准的发展

2014-09-07

科室
- - 订阅+
  - 更多科室
工具
服务